Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Nature|March 24, 2022
Androgen receptor activity in T cells limits checkpoint blockade efficacyXiangnan Guan, Fanny Polesso, Chaojie Wang, et al.Journal for Immunotherapy of Cancer|May 8, 2019
Automated image analysis of NSCLC biopsies to predict response to anti-PD-L1 therapySonja Althammer, Tze Heng Tan, Andreas Spitzmüller, et al.Oncoimmunology|September 14, 2016
Targeting CD73 in the tumor microenvironment with MEDI9447Carl M Hay, Erin Sult, Qihui Huang, et al.Journal for Immunotherapy of Cancer|May 19, 2026
Pan-cancer analysis in the real-world setting uncovers immunogenomic drivers of acquired resistance post-immunotherapyMohamed Reda Keddar, Sebastian Carrasco Pro, Roy Rabbie, et al.Cancer Research|December 25, 2013
Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cellsJérémy Goc, Claire Germain, Thi Kim Duy Vo-Bourgais, et al.Nature Communications|January 24, 2024
Tumour-retained activated CCR7<sup>+</sup> dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activityColin Y C Lee, Bethany C Kennedy, Nathan Richoz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2022
Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid TumorsJonathan W Goldman, Sarina A Piha-Paul, Brendan Curti, et al.Frontiers in Immunology|March 25, 2021
Tertiary Lymphoid Structure-B Cells Narrow Regulatory T Cells Impact in Lung Cancer PatientsClaire Germain, Priyanka Devi-Marulkar, Samantha Knockaert, et al.Cancer Immunology Research|May 7, 2015
Identification and Characterization of MEDI4736, an Antagonistic Anti-PD-L1 Monoclonal AntibodyRoss Stewart, Michelle Morrow, Scott A Hammond, et al.The Journal of Experimental Medicine|April 26, 2022
In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissueZhi Li, Zewen K Tuong, Isaac Dean, et al.Pageof 5